Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022 - 2024)

Perspective Therapeutics (CATX) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 5070000.0 in Q1 2024.

• For the quarter ending Q1 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 5070000.0; the trailing twelve-month figure through Mar 2024 stood at 5070000.0 (changed N/A YoY), and the FY2023 full-year result was 5072000.0, up 1737.68% from the prior year.
• Liabilities from Discontinued Operations steadied at 5070000.0 in Q1 2024, from 5072000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 5072000.0 in Q4 2023 to a low of 276000.0 in Q4 2022.
• A 3-year average of 3472666.67 and a median of 5070000.0 in 2024 frame the typical range for Liabilities from Discontinued Operations.
• Peak annual rise in Liabilities from Discontinued Operations reached 1737.68% in 2023, while the deepest fall reached 1737.68% in 2023.
• Tracing CATX's Liabilities from Discontinued Operations over 3 years: stood at 276000.0 in 2022, then surged by 1737.68% to 5072000.0 in 2023, then slipped by 0.04% to 5070000.0 in 2024.
• Business Quant data shows CATX's Liabilities from Discontinued Operations at 5070000.0 in Q1 2024, 5072000.0 in Q4 2023, and 276000.0 in Q4 2022.